USE OF PHYTOSTEROLS

Phytosterols combined with fatty alcohols restore and protect the skin microbiota, addressing disruptions caused by aggressive agents in cosmetic products, improving skin radiance and reducing imperfections.

FR3085839B1Active Publication Date: 2025-12-12BASF BEAUTY CARE SOLUTIONS FRANCE SAS
0 Cites 0 Cited by

Patent Information

Application Number
FR2018058219
Authority / Receiving Office
FR · FR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2018-09-13
Publication Date
2025-12-12
Estimated Expiration
2038-09-13

AI Technical Summary

Technical Problem

Existing cosmetic and hygiene products containing aggressive agents disrupt the skin microbiota, leading to unsightly and uncomfortable manifestations such as dry skin, dandruff, skin desquamation, and skin tone imperfections, without effectively addressing the balance of commensal and pathogenic bacteria.

Method used

The use of phytosterols, preferably from rapeseed oil, combined with fatty alcohols like cetearyl alcohol, helps maintain and restore the balance of commensal and mutualistic skin bacteria while reducing the proliferation of pathogenic bacteria, by applying them topically in compositions like creams, lotions, and shampoos.

Benefits of technology

Phytosterols effectively restore and protect the skin microbiota, enhancing skin radiance and tolerance to aggressive agents, reducing skin imperfections and discomfort, and maintaining a healthy skin appearance.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to the cosmetic use of phytosterols to protect and / or restore the skin microbiota and / or to prevent and / or reduce the unsightly, unpleasant, and / or uncomfortable manifestations of skin microbiota alteration. It further relates to a cosmetic treatment method comprising the topical application of phytosterols to at least one area of ​​skin, advantageously the scalp, to protect and / or restore the skin microbiota and / or to prevent and / or reduce the unsightly, unpleasant, and / or uncomfortable manifestations of skin microbiota alteration.Finally, it concerns phytosterols for their use in the treatment and / or prevention and / or reduction of the occurrence of a pathology associated with an alteration of the skin microbiota, in particular chosen from the group consisting of acne, psoriasis and bacterial and / or fungal infections, ulcers, herpes, boils, folliculitis, abscesses, sycosis, impetigo, ecthyma, erysipelas, mycoses such as candidiasis or dermatophytoses such as ringworm and / or scabies, pigmentary and / or acne scars as well as their combinations and / or in the treatment and / or prevention of superinfection of wounds and / or in the prevention of spots.
Need to check novelty before this filing date? Find Prior Art